1. Introduction {#s0005}
===============

Being the seventh leading cause of death globally, diabetes mellitus, resulted in 1.4 million deaths in the year 2011 (approximately 2.6 percent of entire worldwide deaths for the same year) ([@b0340]). Neuropathy is one of the most common risks associated with diabetes, this condition affects 20 percent of adults with diabetes currently, and in the long run, it will affect about 50 percent of all adults with diabetes. There are different forms of diabetic neuropathy that can be classified further through focal or diffuse neuropathy ([@b0085]).

Having sensory neuropathy being the most frequently experienced, diabetic neuropathy comprises of autonomic, motor and sensory nerve lesions. The DN's main clinical features include progressive loss of movement and sensation within the distal limbs, showing symptoms such as intense numbness of limbs, weakness and muscles atrophy, severe pain, and weakening or total loss of tendon reflexes, eventually resulting to foot ulcers, infection and in other cases, amputation ([@b0200]). The symptoms lead to a several disease burden in relation to disability and exhaustion of resources for health care ([@b0035]).

Since ancient times, human diseases are believed to be treated using medicinal plants ([@b0065]). Use of medicinal plants has been on significant rise in the recent years in comparison with chemical drugs due to various factors, such as low-cost, easy access without prescription, considering the natural products have less side effects, as well as no need to refer to medical advice. ([@b0050]).

*Nigella sativa* NS is a flowering from the family *Ranunculaceae*. It is a therapeutic plant that grows in different places all over the world especially Saudi Arabia, Syria, Pakistan and Turkey ([@b0010]). It is considered as enriched source of nutritionally vital constituents and its oil contains polyunsaturated fatty acids (PUFA), as well as other several phytochemicals that exhibit strong antioxidant properties and cause lowering effect on glucose ([@b0110]).

In the food industry, silver nanocomposites and nanoparticles remain among the most commonly used nanomaterials. They are used as antimicrobials. Silver nanoparticles can be used as a source of Ag ions, that bind to membrane proteins, and catalyze the generation of ROS in bacterial cells. This causes cell death due to oxidative stress ([@b0185]). However, a number of research studies done in the recent years indicated that silver nanocomposites are safe and can be used for food packaging, with insignificant levels or no detectable level of silver nanoparticles produced and moved from containers into actual samples of food ([@b0075]).

In KSA, a diagnosis was carried on out on 552 patients with diabetes mellitus where they were found to have diabetic neuropathy ([@b0300]). In a study carried out in KSA, of 91 patients with foot ulcer, the incidences of lower extremity amputation were 29.7 percent, and there was a rise of amputation risk in patients with peripheral arterial disease and diabetic neuropathy, especially those patients with a more advanced infection and ulceration stage ([@b0015]). In a cross-sectional study of three hundred and fifty diabetic patients who were present at a primary care in KSA, the occurrence of peripheral vascular and peripheral neuropathy disease was 15% and 47.5% respectively. In a specialist diabetes center in Riyadh, a cross-sectional study involving 351 patients with diabetes was carried out where diabetic neuropathy, was found in 22.8% of the patients ([@b0210]). A research carried out by [@b0205] demonstrated that the speed through which the cells up took the nanoparticles, might be the typical reason for their capability to enhance the antioxidant capacity inside the brain cells

Several synthetic techniques have been employed for the synthesis of silver-based nanoparticles in relation to biochemical, physical and chemical methods. ([@b0140]). Due to the use of noxious stabilizing and/or reducing agents such as N, N-dimethylformamide, toxic agents and sodium borohydride, chemical-based methods are not recommended ([@b0045]). With the increasing attention on green chemistry, natural compounds such as soluble starch, glucose, chitosan and certain microorganisms ([@b0270]), have become a focal point for researches as low toxic alternatives, stabilizing and reducing agents to the silver nanosphere's synthesize. The use of biochemical routes to synthesize nanoparticles through plant extracts as capping and reducing agents, has been given a lot of special attention among others conferring the silver nanoparticles with extra properties of pharmacology ([@b0245]). As a result, medicinal plants are being largely utilized for the shape and size- controlled synthesis of silver nanoparticles since these plants have proven to be significant in therapeutic uses ([@b0045]).

In the present study, we focused on the antidiabetic, anti-inflammatory together with antioxidant effect of silver nanoparticles prepared by using *Nigella sativa* extract in experimental model. Furthermore, we would like to explore the beneficial effect of this combination in ameliorating neurodegeneration accompanied diabetes.

2. Materials and methods {#s0010}
========================

2.1. Animals and chemicals {#s0015}
--------------------------

50 male albino rats (200 ± 10 g) were divided into 5 groups (10 rats in each). Rats received water *ad libitum* in addition to Standard laboratory diet.

2.2. Preparing the plant extract {#s0020}
--------------------------------

Briefly, according to [@b0150], 100 g of powdered seeds *Nigella Sativa* was mixed in a Soxhlet extractor with 70% ethanol. The final extract yielded 32% was then concentrated under low pressure and stored at −20 °C until being used.

2.3. Preparing Silver nanoparticles {#s0025}
-----------------------------------

Chemical reduction method has been used in the preparation of Silver nanoparticles as reported by [@b0195].

2.4. Green synthesis of silver nanoparticles using nigella sativa {#s0030}
-----------------------------------------------------------------

5 ml of aqueous extract of (NS) was placed and paced on the stirrer that is magnetic with hot plate. Then 50 ml of 1 Mm silver nitrate solution was added to this in drops and stirred continuously 120 rpm at 100 °C. The way the color of the solution changed was checked from time to time. The changes from yellow to brown color of the solution shows the formation of AgNPs ([@b0170]).

2.5. Characterization of silver nanoparticles {#s0035}
---------------------------------------------

Scanning Electron Microscopy (SEM) and change in color and UV--Visible were used to characterize synthesized AgNPs. Through visual observation, a change of color was observed in the flask which has AgNO~3~ solution with extracts.

2.6. UV--Visible spectroscopy {#s0040}
-----------------------------

UV--Visible spectrophotometer was used to confirm the formation of AG-NPs. The sample's UV-V absorption spectrum was carried out in Perkin Elmer Spectrophotometer, at diverse time 5, 10, 20 min after extracting step, AgNO~3~ solution was added to obtain the UV--Visible spectra of the sample [Fig. A](#f0005){ref-type="fig"}.Fig. A

2.7. Scanning electron microscopy {#s0045}
---------------------------------

Scanning Electron Microscopy (SEM) was applied to detect AgNPs' surface morphology. The Ag NPs acquired with *Nigella sativa* was predominantly spherical with 25.2 nm ([Fig. B](#f0010){ref-type="fig"}).Fig. B

*Table/Absorbance of the Ag-NPs of extractsWavelengthSizeAbsorbanceNigella sativa + A(combination)415 nm25.2 nm1.2*

2.8. Experimental induction of diabetic neuropathy {#s0050}
--------------------------------------------------

Stimulation of diabetes was done through the single intraperitoneal injection of streptozotocin (STZ) (50 mg/kg b.w. in 0.1 M citrate buffer (pH = 4.5) that was freshly prepared to rats after overnight fasting. After three weeks rats with high glucose level (more than 250 mg/dl) having glycosuria and hyperglaycemia, were considered as diabetic neuropathy rats and used for the experiment.

2.9. Experimental design {#s0055}
------------------------

Group (1): Healthy control rats treated by saline daily Group (2): Diabetic Neuropathy (DN) group (Streptozotocin intraperitoneally injected (50 mg/kg) to induce diabetic neuropathy Group (3): Diabetic Neuropathy group treated with AgNPs in oral dose of (0.25 mg/kg bw) daily for 21 days. (4): Diabetic Neuropathy group treated with *Nigellia Sativa* extract in oral dose of (200 mg/kg bw. ip) daily for 21 days. Group (5): Diabetic Neuropathy group treated with AgNPs prepared by *Nigellia Sativa* extract in oral dose of (200 mg/kg bw. ip) daily for 21 days.

Animals were anaesthetized by sodium thiopental injection, blood samples were obtained by retro-orbital bleeding at the end of experimental period. Then, sera were separated for subsequent use of different biochemical measurements. Rats were then decapitated, and their brain cautiously dissected and extraneous tissues were removed, and apart of brain tissue was directly moved to 10% formalin for histopathological assessments. For gene expression, the second part was preserved at −80 °C, homogenization was done on the other part using 0.1 M phosphate buffer saline at pH7.4, in order to get ultimate concentration of 10% w/v and centrifuged at 3000xg for fifteen minutes at −4 °C. The resulting supernatant was utilized for subsequent biochemical assessments.

3. Biochemical analysis {#s0060}
=======================

Glucose level was measured using peripheral blood from the tail by (one touch sure step meter life scan, CA). Serum insulin and advanced glycation end product (AGE) were measured using Eliza Kit (Cayman chem., Ann Arbor, MI, USA; Cat. No: 589501) according to manufacture instruction. TNF-α, Nuclear factor Kappa B (NFκB), S-100B were measured using sandwich enzyme-connected immunosorbent assay (ELISA) method (provided by WKEA Med Supplies Corp., Changchun, China) and (Human S100B, BioVendor, No: RD192090100R) respectively. Serum Aldose reductase, was also measured. Brain Antioxidant Status Includes malondialdehyde (MDA), nitric oxide (NO) levels, glutathione (GSH) were also measured according to manufacture instruction. Moreover, nitrotyrosine was measured using Eliza immunoassay (HyCult Biotechnology, Holland). Histopathological analysis was performed on brain tissue according to Yoo and Lee (2016).

4. Quantitative real-time polymerase chain reaction (qPCR) {#s0065}
==========================================================

Using Sepasol RNA Super G, Total RNA was obtained from the brain tissue (Nacalai Tesque, Kyoto, Japan) and transcribed in reverse using ReverTra Ace- PCR RT Master Mix with genomic DNA Remover (Toyobo Co., Osaka, Japan) in relation to protocol of the manufacturer.

The sequences of the primers utilized for NGF and TrkA are listed below: NGF primers, forward, 50-ACCTCTTCGGACACTCTGG-30, and backward, 50-CGTGGCTGTGGTCTTATCTC-30; trkA primers, forward, 50-CCATGCTACAGCACCAACAC-30, and backward, 50-AAGGACCAGGAGCCACATC-30; qPCR was achieved through the use of a Bio- Rad iCycler - qPCR system as well as SYBR- Ex Premix taq™ (Takara Bio Inc., Shiga, Japan). All the primer pairs had cycling conditions as shown below: 5 s at 95 °C and 30 s at 60 °C, as per the protocol of the manufacturer. The ratios of NGF and trkA mRNA expression to the β actin level in the different samples were taken into consideration based on the different levels of mRNA and are expressed based on the mRNA levels of the control group (Obata *et al.,* 2006). Data are indicated as mean ± SE.

4.1. Statistical analysis {#s0070}
-------------------------

The results of the current study were carried as Mean + SE. Data analyzation was done through ONE WAY analysis of variance (ANOVA) utilizing the Statistical Package for the Social Sciences (SPSS) program. Variance was recognized to be significant when P value was \<0.05.

5. Results {#s0075}
==========

[Fig. 1](#f0015){ref-type="fig"} illustrates the effect of AgNPs, *nigella sativa* and their combination on serum level of glucoses, insulin, aldose reductase and AGE in all groups. It is clear from this figure that, there was significant increase (P \< 0.05) in blood glucose, AGE and aldose reductase levels in Diabetic neuropathy induced group accompanied by a significant decline (P \< 0.05) in insulin concentration as compared to control group. Groups treated with AgNPs, *Nigella sativa* and their combinations, showed significant decrease (P \< 0.05) in glucose and AGE and aldose reductase level comparing with DN induced group, on the other hand, insulin level increased significantly (P \< 0.05) in treated groups as compared to DN induced group. Our results from [Fig. 2](#f0020){ref-type="fig"} revealed significant elevation in inflammatory biomarkers (TNF-α, NFκB and S100B) in Diabetic neuropathy induced groups as compared to healthy control. While treatments with AgNPs, *Nigella sativa* and their combination remarkably ameliorate inflammatory markers comparing to Diabetic neuropathy induced group. Nano silver prepared using *Nigella sativa* extract (green synthesis) showed the best effect as compared to other treatments. Regarding the oxidative stress status, It is clear from the present data ([Fig. 3](#f0025){ref-type="fig"}) that there was significant elevation (P \< 0.05) in brain MDA, NO content in Diabetic neuropathy induced group accompanied by significant decline (P \< 0.05) in SOD and GSH as compared to healthy control group. All the other treatment remarkably attenuates oxidative status in DN induced rats. [Fig. 4](#f0030){ref-type="fig"} illustrates the level of nerve growth factor and nitrotyrosine and TKr A in all treated groups. Results revealed a significant elevation (P \< 0.05) in expression of nerve growth factor associated by decrease (P \< 0.05) in TKr A level in DN induced group when compared to healthy control group, while expression of nitrotyrosine significantly reduced (P \< 0.05). Groups treated with either AgNPs, *nigella sativa* or their combinations showed significant (P \< 0.05) improvement of these biomarkers.Fig. 1Effect of different treatments on serum levels of Glucose, Insulin and AGEs a: Significantly different from (normal control) group value at p \< 0.05. b: Significantly different from (Diabetic Neuropathy) group value at p \< 0.05. c: Significantly different from (Diabetic Neuropathy + AgNP) group value at p \< 0.05. d: c: Significantly different from (Diabetic Neuropathy + *Nigella Sativa*) group value at p \< 0.05.Fig. 2Effect of different treatments on serum levels of TNF-α, NF-kB and S-100B, a: Significantly different from (normal control) group value at p \< 0.05. b: Significantly different from (Diabetic Neuropathy) group value at p \< 0.05. c: Significantly different from (Diabetic Neuropathy + AgNP) group value at p \< 0.05. d: c: Significantly different from (Diabetic Neuropathy + *Nigella Sativa*) group value at p \< 0.05.Fig. 3Effect of different treatments on serum levels of MDA, NO, SOD and GSH, a: Significantly different from (normal control) group value at p \< 0.05. b: Significantly different from (Diabetic Neuropathy) group value at p \< 0.05. c: Significantly different from (Diabetic Neuropathy + AgNP) group value at p \< 0.05. d: c: Significantly different from (Diabetic Neuropathy + *Nigella Sativa*) group value at p \< 0.05.Fig. 4Effect of different treatments on expression of Nerve Growth Factor, trKA, and Nitrotyrosine. a: Significantly different from (normal control) group value at p \< 0.05. b: Significantly different from (Diabetic Neuropathy) group value at p \< 0.05. c: Significantly different from (Diabetic Neuropathy + AgNP) group value at p \< 0.05. d: c: Significantly different from (Diabetic Neuropathy + *Nigella Sativa*) group value at p \< 0.05.

Interestingly, group treated with green synthesis of nano silver prepared by *nigella sativa* extract showed the best effect between all other treatment.

5.1. Histological findings {#s0080}
--------------------------

See [Fig. 5](#f0035){ref-type="fig"}.Fig. 5Photomicrograph of brain tissue (A) healthy control group showing normal brain parenchyma with normal nerve cells and neurons, (score lesion: 0), (H&E X 400); (B) Diabetic neuropathy group showing severe intracellular neuronal edema (arrow) with marked demyelination of nerve fibers (nerve arrow), (lesion score: +++), (H&E X 400); (C) Diabetic neuropathy + AgNPs group, showing low frequent neuronal edema (arrow), with slight nerve fibers demylenation (arrow head), (score lesion: +), (H&E X 400); (D) Diabetic neuropathy + *Nigella Sativa* group showing massive areas of neuronal degeneration (arrows) with severely degenerated nerve fibers (arrow head), (score lesion: +++), (H&E X 400);(E) Diabetic neuropathy + Combination group showing multifocal areas of neuronal degenerations (arrows) together with vacuolation of nerve fibers (arrow head), (score lesion: ++), (H&E X 400).

6. Discussion {#s0085}
=============

Diabetic neuropathy is a pathology that grow on fast rate and should have a global concern. In most cases, diabetic neuropathy starts as a fiber neuropathy that is small and influenced by serum glucose levels. Factors that play significant roles in this pathophysiological process include low blood flow and increased serum glucose levels ([@b0020]). Therefore, it is important to discover new compounds and treatment techniques to avoid diabetes risks ([@b0280]). In this section, the ameliorative potential of green synthesis of AgNPs is discussed through the use of *Nigella sativa* extract on diabetic neuropathy in the model of a rat of Streptozotocin -induced diabetes. Streptozotocin STZ destroys pancreas cells that produce insulin and is usually used as an experimental model for diabetes ([@b0120])

6.1. Effect of different treatments on serum levels of glucose, aldose reductase and AGEs {#s0090}
-----------------------------------------------------------------------------------------

Results showed that, Diabetic neuropathy rat group had an elevation in serum levels of glucose, aldose reductase and AGEs accompanied by reduction in insulin level. High levels of blood glucose, results in several health risks including neuropathy, renal failure, blindness etc. In addition, elevated levels of glucose in blood encouraged auto-oxidative glycosylation, generation of a product of glycation, stimulation of kinase-C protein and nuclear transcription factor (NF-kB) ([@b0180]). For a mammalian brain, glucose is the major source of energy, according to ([@b0135]), neuron is the part that require the most energy in the brain of an adult, demanding uninterrupted delivery of glucose from blood. Our findings agreed with [@b0325] who demonstrated that diabetic neuropathy induces metabolic imbalance and induces hyperglycemia. Similar results have been demonstrated in both type 1 and 2 diabetic rodent models ([@b0350]). Hyperglycemia in patients suffering from diabetes is concerned with, oxidative and glycosylation damage to proteins, fats and nucleic acids leading to structural and functional damage of nerve fibers, with diabetic neuropathy development ([@b0025]).

Advanced glycation end product AGEs have been considered as possible biomarkers for diagnosing diabetes complications. AGEs are generated through a non-enzymatic reaction of glucose using amino groups on amino acids from proteins during diabetes ([@b0315]). The increased levels of AGEs were due the effect of diabetes on increasing receptors of AGEs, induction of inflammatory cascade and generation of RNS and ROS, leading to cellular damage and dysfunction ([@b0320]). Additionally, the AGEs encourage vascular and neuronal alteration of protein, leading to vasoconstriction of the neuronal blood vessel and neuronal dysfunction, following deprivation of neuronal cells from its source of blood ([@b0130]).

It was noticed in the present study that, treatment with either *Nigella sativa* or AgNPs, modified these level parameters, *Nigella sativa* have conveyed activities that lower glucose in the earlier literature in different mechanisms of action and considered as pancreas protective herb ([@b0155]). As stated by [@b0055], *Nigella sativa's* ethanolic extract has the property of proliferation and regeneration of beta cells in the pancreas. It also has the capability of improving the glucose uptake, as well as inducing insulin secretion from beta cells in pancreas. Furthermore, [@b0125] considered *Nigella sativa* as a herb that used in treating diabetes and several other diseases. A study by [@b0005] exposed that, volatile fractions and *N. sativa* lipid holds insulinotropic properties and retains the integrity of β-cells that improve the production of the insulin which is vital in facilitating diabetes mellitus. These results strongly support our findings.

Regarding antidiabetic effect of AgNPs, it has established to make an increase in the bone's mineral density making it easy for the β-cells of the pancreas to release insulin through a related pathway, of the sulfonylureas that are presently utilized in the therapy for anti-diabetic. This due to their ability to induce endogenous insulin secretions, as well as to enhance the uptake of glucose and its usage inside the muscle and plays the role of free radical scavenger reducing oxidative stress in rat models that are diabetic ([@b0030]).

6.2. Effect of different treatments on TNF-α, NF- ĸB and S-100B {#s0095}
---------------------------------------------------------------

In our study, results obtained from diabetic neuropathy group showed an increase in serum levels of TNF-α, NF- ĸB and S-100B as compared to control rats.

During diabetes, inflammation can be triggered through an increase in reactive oxygen species ROS ([@b0060]). NFκB, which is a transcription aspect that controls the expression of proinflammatory genes, can be activated by ROS ([@b0235]).

Glucose auto-oxidation and excessive production of ROS is strongly induced by hyperglycemia. Protein kinase C is activated by excess ROS and then NFκB, resulting to injury. Being a redox-sensitive protein complexes, NFκB has a major function in inflammation ([@b0165]). Activated NFκB encourages the transcription, as well as, the release of inflammatory mediators, for instance, tumor necrosis factor-α TNF-α and thus, provoking inflammation ([@b0255]). Previous study by [@b0305] reveal that, enhancement in serum levels of proinflammatory cytokines like TNF-a represents the state of insulin resistance.

The S100 proteins, a family of calcium-binding cytosolic proteins, have a broad range of intracellular and extracellular functions through regulating calcium balance, cell apoptosis, migration, proliferation, differentiation, energy metabolism, and inflammation ([@b0100]). An increased S100B expression has been recorded inside the plasma and adipose tissue of obese animals ([@b0080]). A close connection between increased levels of S100B and insulin resistance has been indicated. The secretion of pro-inflammatory cytokines in the adipose tissue such as TNF-α is usually controlled by adipocyte derived S100B ([@b0345]).

Administering a combination of *Nigella sativa* extract and Silver NPs modulated the inflammatory biomarkers. The anti-inflammatory effect of *Nigella sativa* has been previously demonstrated in several inflammation-based models ([@b0175]). These results agreed with [@b0295] who stated that AgNPs possesses anti-inflammatory activities. Interestingly, several Ag-NPs' studies have illustrated cytoprotective activities, both *in vitro* and *in vivo* ([@b0285]). In addition, *in vitro* experimental data assigned AgNPs anti-inflammatory impact and the role it plays in the process of healing wounds through lowering the levels of TNF-α, interferons and interleukin 1, as well as, inhibition of COX-2 and MMP-3 expressions ([@b0115]). As it was also discovered, silver NPs has the potential of hindering the activities of TNF-α which are involved in inflammations ([@b0275]).

6.3. Effect of different treatments on oxidative stress biomarkers {#s0100}
------------------------------------------------------------------

Results revealed that Diabetic neuropathy could affect oxidative parameters as it increases serum levels of MDA and NO with a parallel reduction in SOD and GSH. These enzymes act as a major factor in the removal of free radicals from the tissues and they get protected from the impact of oxidative stress through their high expression and activities levels in brain cells ([@b0225]). The cell's components such as, DNA, protein and lipids are severely damaged by oxidative stress ([@b0105]). In diabetic neuropathy, endothelial function is severely affected by insulin resistance resulting to reduced synthesis of nitric oxide NO. Superoxide and nitric oxide combine rapidly in solution which produce a potent protein-oxidizing agent called peroxynitrite. Through the detection of nitrotyrosine residues in the protein, the peroxynitrite concentrations can be monitored indirectly, showing the amount of damage caused by oxidative stress ([@b0250]). It is a major factor in the neuronal degeneration since it activates the extracellular modulation, inflammatory cascade and autoimmune apoptosis. The inflammatory mediators such as TNF-α, NF-κβ are activated by the production of ROS in neuronal cells.

Results indicated that the oxidative stability was impaired by diabetic neuropathy ([@b0230]). Among the several mechanisms that lead to induction of oxidative stress in diabetes is the disruption in the mitochondrial electron transport sequence, caused by excessive levels of glucose, that lead to a superoxide anions' overproduction ([@b0240]). Previous studies by [@b0260], [@b0310] indicated increased serum MDA concentration in diabetic patients as well as a reduction in plasma total antioxidant capacity TAC which confirmed our findings.

After treatment with either *Nigella sativa* or AgNPs, or combination of them, the antioxidant status is restored significantly in comparison to the diabetic neuropathic group. Our results agreed with [@b0160] who stated that administering *Nigella sativa* in STZ-induced diabetic rats, may protect pancreatic β-cells, and reduce the concentration of pancreatic MDA and serum levels of nitric oxide. *Nigella sativa* has protective activities by induction of endogenous anti-oxidative enzymes, scavenging superoxide, and inhibition of NF-κB ([@b0265]). Additionally, it indicated the efficacy of *Nigella sativa* antioxidant property in preventing environmental toxic agent-induced oxidative stress.

6.4. Effect of different treatments on expression of nerve growth factor, trKA, and nitrotyrosine {#s0105}
-------------------------------------------------------------------------------------------------

A diabetic state encourages delay in the generation of nerves during diabetic neuropathy ([@b0215]). [@b0330] reviewed different factors relating to nerve regeneration factor NGF that are recorded to cause a down-regulation during experimental neuropathy in diabetic rodents. Additionally, through the stimulation of a receptor tropomyosin kinase receptor A, the mature NGF can apply its biological action.

According to the *in vitro* and *in vivo* results, NGF promotes differentiation, role and survival of sympathetic nerve and peripheral sensory cells. These results suggest that an NGF that is purified might be of great importance in the prevention and/or protection of peripheral nerve degeneration, for instance, those that occur in diabetes, surgical traumas and leprosy ([@b0040]). Our result was in line with [@b0220] which covered an experimental model of diabetic neuropathy illustrating how the early increase of peripheral and spinal NGF, was linked to the development of thermal hyperglycaemia and hyperalgesia. The results achieved in this study were in line with [@b0090] which stated that there was a significant increase of fasting nitrotyrosine in diabetic patients.

Several studies revealed that *Nigella sativa* has pharmacological properties among them are the neuroprotective improvement of neurodegenerative illnesses, as well as memory enhancement ([@b0145]). A previous study by [@b0335] evaluated the *Nigella sativa* protective effect against Chlopyrifos which has been linked to the pathophysiology of many neurodegenerative illnesses. On the other hand, concomitant administration of ethanolic extract of *Nigella sativa*, suppressed the increased hippocampal NO levels in the rats that were exposed, and as a result inferred to lower neuro-inflammation ([@b0190])

6.5. Histological findings {#s0110}
--------------------------

Histological changes were extremely noticed in tissues inside the brain of Diabetic neuropathic rats. The brain cells can be affected directly by diabetes, through the production of an oxidative stress resulting to apoptosis. The main tool is demonstrated a rise in glucose metabolism because of hyperglycemia that stimulates the respiration of mitochondrial, leading to the release of superoxide and other reactive nitrogen or oxygen species into the cytoplasm ([@b0350]).

7. Conclusion {#s0115}
=============

We provide the evidence that, green synthesis of AgNPs using *nigella sativa* extract has a promising antidiabetic effect with special reference to one of the most complications of diabetes (diabetic neuropathy) via their ability to mitigate hyperglycemia, oxidative stress, inflammation, and apoptosis. Further studies are required to find other mechanisms involved in this action.
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